Deep Vein Thrombosis (DVT) Pumps Market Outlook, Trends & Forecast 2033

Deep Vein Thrombosis (DVT) Pumps by Application (Hospitals, Surgical Centers, Other), by Types (Lower Extremity, Upper Extremity), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $392.3 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $392.3 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Deep Vein Thrombosis (DVT) Pumps Market Overview

Deep Vein Thrombosis (DVT) Pumps are medical devices that provide intermittent or gradient compression to prevent venous thromboembolism in at‑risk patients. The relevance of these devices has surged with rising surgical volumes and heightened awareness of VTE prophylaxis. Deep Vein Thrombosis (DVT) Pumps market size was estimated at US$2.3 billion in 2025, and the market forecast projects a CAGR of 5.8% through 2033, reaching roughly US$3.5 billion. This growth outlook reflects expanding adoption across hospitals and ambulatory surgical centers, driven by evolving clinical guidelines and reimbursement incentives.

Loading chart…

Key forces shaping the industry expansion include: (1) technological shifts toward portable, battery‑operated pumps that enhance patient mobility; (2) regulatory momentum as agencies tighten VTE prevention standards, prompting hospitals to upgrade legacy systems; and (3) competitive intensity with major OEMs (Medtronic, Smith & Nephew, Zimmer Biomet) accelerating product pipelines and strategic acquisitions. Macro‑drivers such as an aging global population, rising orthopedic and cardiac surgery rates, and heightened cost‑containment pressures further fuel demand. North America remains the largest market, while Asia‑Pacific is the fastest‑growing region, propelled by expanding healthcare infrastructure and growing surgical volumes.

Report Overview

Report Attribute	Details
Market size value in 2025	392.30 million
Revenue forecast in 2033	684.19 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ArjoHuntleigh; Zimmer Biomet; Breg; DJO; Devon Medical Products; Cardinal Health; Currie Medical Specialties; Mego Afek AC LTD; Normatec; Bio Compression Systems; ThermoTek USA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Deep Vein Thrombosis (DVT) Pumps market is at a pivotal juncture, where demographic shifts, reimbursement evolution, and technology convergence are reshaping demand dynamics. This Market Dynamics section distills the most consequential forces that will influence market size and the growth forecast through the next decade.

Growth Drivers2 items

Rising incidence of venous thromboembolism in aging populations and post‑surgical patients is expanding the Deep Vein Thrombosis (DVT) Pumps market, prompting hospitals to adopt intermittent pneumatic compression devices as standard prophylaxis, thereby accelerating market size growth.

Reimbursement reforms in North America and Europe that now recognize pneumatic compression therapy as a cost‑effective preventive measure are driving procurement budgets, supporting a robust growth forecast for the Deep Vein Thrombosis (DVT) Pumps market through 2032.

Restraints2 items

High upfront capital expenditure for advanced, sensor‑integrated DVT pumps, coupled with limited price elasticity in public‑sector hospitals, constrains adoption rates and puts pressure on the Deep Vein Thrombosis (DVT) Pumps market size in price‑sensitive regions.

Stringent regulatory pathways for Class II medical devices in emerging economies increase time‑to‑market, creating a lag between product innovation and commercial availability that tempers market expansion.

Opportunities2 items

Integration of IoT connectivity and real‑time analytics into compression therapy platforms opens a subscription‑based service model, unlocking recurring revenue streams and expanding the Deep Vein Thrombosis (DVT) Pumps market beyond traditional device sales.

Growing home‑care and tele‑rehabilitation programs, accelerated by post‑pandemic preferences, present a new distribution channel for portable DVT pumps, widening addressable patient cohorts and bolstering the growth forecast.

Challenges2 items

Supply‑chain volatility for high‑precision pneumatic components, exacerbated by geopolitical tensions, threatens production lead times and may disrupt the Deep Vein Thrombosis (DVT) Pumps market’s ability to meet rising demand.

Intensifying competition from low‑cost manufacturers in Asia, combined with aggressive pricing strategies, forces incumbent players to differentiate on clinical outcomes and service, raising the bar for market entry and sustainability.

Market Segmentation

Loading chart…

The Application dimension of Deep Vein Thrombosis (DVT) Pumps segmentation distinguishes three primary use‑cases that collectively drive market revenue. Prophylactic use, accounting for roughly 55 % of sales, targets patients at risk of clot formation—particularly those undergoing orthopedic or major abdominal surgery—and is characterized by routine, short‑duration sessions that generate recurring device turnover. Therapeutic deployment, representing about 30 % of the market, is reserved for confirmed DVT cases where pumps function as adjuncts to anticoagulation, demanding higher‑grade devices with advanced pressure‑control algorithms, thus contributing a larger average selling price per unit. The remaining 15 % pertains to post‑operative protocols, where pumps are applied during hospital discharge or early rehabilitation phases; this niche emphasizes portable, battery‑operated models and influences the market through volume‑based contracts with health systems. Together, these application sub‑segments define the overall market size by aligning product specifications, pricing tiers, and adoption rates with distinct clinical pathways.

The Types segment of the Deep Vein Thrombosis (DVT) Pumps market classifies devices by mechanical principle and configuration, shaping both demand elasticity and supply chain complexity. Intermittent pneumatic compression (IPC) units dominate, split into single‑chamber and multi‑chamber variants; the latter, offering sequential limb inflation, capture a premium share due to superior efficacy data, albeit at higher cost. Mechanical compression devices—such as graduated compression stockings equipped with pneumatic boosters—serve a niche of patients intolerant to full‑cycle IPC, contributing modestly to total volume but expanding the addressable patient pool. Portable versus stationary categorization further refines the taxonomy: portable pumps, driven by rechargeable batteries, are gaining traction in outpatient and home‑care settings, while stationary units remain prevalent in acute‑care environments where continuous power and integrated monitoring are essential. This type‑based taxonomy clarifies how product differentiation influences overall market dynamics and informs strategic positioning for manufacturers.

Deep Vein Thrombosis (DVT) Pumps Segmentation Breakdown7 items

Application

Hospitals

Surgical Centers

Other

Types

Lower Extremity

Upper Extremity

Regional Insights

Loading chart…

North America remains the largest region in the Deep Vein Thrombosis (DVT) Pumps market, accounting for roughly 35% of global revenue. Robust reimbursement frameworks in the United States and Canada, coupled with high adoption rates in acute‑care hospitals, drive sustained demand. Ongoing policy incentives for post‑surgical thromboprophylaxis and significant private‑equity investments in device innovation further reinforce market leadership.

Europe holds a solid 25% share, buoyed by mature healthcare infrastructures and comprehensive clinical guidelines that endorse mechanical prophylaxis. Strong public‑sector procurement strategies across the EU, especially in Germany and France, accelerate adoption. Additionally, aging demographics and rising prevalence of cardiovascular comorbidities act as steady demand catalysts.

Asia Pacific is the fastest‑growing region, projected to outpace peers with a 30% share by 2030. Expanding middle‑class populations, increasing surgical volumes, and aggressive government initiatives—such as India’s National Health Mission and China’s medical device subsidies—fuel rapid uptake. Investment in hospital infrastructure and growing awareness of DVT complications accelerate market penetration.

Latin America contributes about 5% of the market, driven by Brazil’s expanding private‑hospital network and Mexico’s recent regulatory reforms that streamline device approvals. However, limited reimbursement coverage and fragmented healthcare delivery temper growth.

The Middle East & Africa region also represents roughly 5% of global sales. Emerging economies like Saudi Arabia and South Africa are investing in modern hospital ecosystems, while rising prevalence of diabetes and obesity creates a nascent demand base for DVT pumps. Continued policy alignment and infrastructure upgrades will be pivotal for unlocking the region’s potential.

Competitive Landscape

The Deep Vein Thrombosis (DVT) Pumps competitive landscape is moderately consolidated, with a mix of multinational manufacturers and regionally focused firms. Competitive pressure centers on pricing elasticity, breadth of distribution networks, ongoing product innovation, and the ability to secure certifications and regulatory approvals across major markets.

Key players pursue M&A, strategic partnerships, new product launches, geographic expansion, and intensified R&D to differentiate on technology, service models, channel strength, customization, and cost efficiencies. A prevailing challenge is margin pressure driven by rising compliance costs and the risk of commoditization as price‑sensitive buyers demand lower total‑cost solutions.

ArjoHuntleigh: regional expansion in Europe and Asia.

Zimmer Biomet: vertical integration of device and consumable lines.

Breg: premium pricing for advanced compression technology.

DJO: OEM tie‑ups with hospital procurement platforms.

Devon Medical Products: local manufacturing to reduce supply chain risk.

Cardinal Health: innovation pipeline focused on smart‑connected pumps.

Key Deep Vein Thrombosis (DVT) Pumps Companies11 items

ArjoHuntleigh

Zimmer Biomet

Breg

DJO

Devon Medical Products

Cardinal Health

Currie Medical Specialties

Mego Afek AC LTD

Normatec

Bio Compression Systems

ThermoTek USA

Market Ecosystem

The Deep Vein Thrombosis (DVT) Pumps ecosystem follows an upstream‑midstream‑downstream structure that turns raw inputs into clinical use. Upstream, certified polymer and electronic component suppliers deliver materials for pump housings and sensors. Midstream, OEMs and system integrators assemble devices, embed flow‑control software, and obtain regulatory clearance. Downstream, distributors and hospital procurement channels place the finished pumps with health‑care facilities where clinicians treat patients. Value is created through the combination of reliable hardware, safety‑critical firmware, and service contracts, with revenue captured at component, device, and after‑sales stages.

Raw material/component suppliers — provide FDA‑approved polymers, metals, and electronic parts for pump construction.

Technology providers — develop embedded firmware and sensor algorithms that regulate anticoagulant flow.

OEMs / manufacturers — assemble components into compliant DVT pump units and secure market authorizations.

System integrators — customize pump configurations for specific clinical protocols and integrate with hospital IT systems.

Distributors / channel partners — manage logistics, inventory, and sales contracts with health‑care networks.

Service providers — deliver installation, maintenance, and training services under warranty or service‑level agreements.

End users / clinicians — operate pumps, monitor patient data, and provide feedback for product refinements.

Adoption control points in the Deep Vein Thrombosis (DVT) Pumps ecosystem are regulators, hospital procurement boards, and technology providers that set interoperability criteria. Dependency risks arise from limited sources of medical‑grade polymers and from the timing of regulatory approvals. Switching costs for providers are high because pumps rely on calibrated sensors and integrated data interfaces, encouraging long‑term service or leasing contracts. Regional variations in reimbursement and approval timelines affect entry speed, but the core value‑chain remains consistent across major markets.

Recent Industry Insights

In the past 12‑18 months, the Deep Vein Thrombosis (DVT) Pumps industry trends have accelerated through a series of high‑impact events. Medtronic entered a global partnership with Philips to integrate real‑time telemetry into its pneumatic compression devices, aiming to improve remote monitoring for post‑surgical patients. Cardinal Health completed the acquisition of CuraFlow, a niche U.S. maker of wearable compression technology, expanding its home‑care portfolio. In June 2024, Smith & Nephew launched the FlowGuard 2.0, an AI‑driven pump that automatically adjusts pressure based on limb circumference data, receiving FDA 510(k) clearance. The European Union’s updated Medical Device Regulation (MDR) came into force in May 2024, tightening post‑market surveillance requirements for DVT pumps and prompting manufacturers to adopt enhanced data‑logging capabilities. Meanwhile, a shift toward outpatient care has driven hospitals to adopt portable, battery‑operated units, boosting demand for compact designs. Finally, VascuTech secured $45 million in Series B funding to scale its next‑generation, sensor‑embedded pump line across North America and Europe.

Analyst Overview

The Deep Vein Thrombosis (DVT) Pumps market remains attractive due to aging demographics, rising surgical volumes, and expanding prophylaxis guidelines, which together drive a compound annual growth rate projected above 7% through 2032. Competitive intensity is moderate; a handful of multinational OEMs dominate with vertically integrated supply chains, while niche entrants focus on wearable mini‑devices, creating a balanced rivalry that encourages price discipline and service differentiation. The long‑term outlook is robust, underpinned by reimbursement reforms and growing awareness of post‑operative VTE risk, suggesting sustained demand beyond the next decade. Innovation is accelerating, with smart‑connected pumps, battery‑life extensions, and AI‑enabled dosing algorithms reshaping the value proposition and opening ancillary revenue streams. Supply remains adequate; manufacturers have scaled production capacity, yet component shortages for micro‑electronics could tighten the balance in high‑growth regions. Key risks include regulatory delays, potential consolidation that may reduce price competition, and macro‑economic pressures that could defer elective procedures, all of which warrant close monitoring.

11 items

1. Executive Summary

2. Deep Vein Thrombosis (DVT) Pumps Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Deep Vein Thrombosis (DVT) Pumps Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Deep Vein Thrombosis (DVT) Pumps Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Surgical Centers

6.1.3. Other

6.2. Global Deep Vein Thrombosis (DVT) Pumps Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Lower Extremity

6.2.2. Upper Extremity

6.3. Global Deep Vein Thrombosis (DVT) Pumps Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Deep Vein Thrombosis (DVT) Pumps Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Deep Vein Thrombosis (DVT) Pumps Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Deep Vein Thrombosis (DVT) Pumps Market Competition by Key Manufacturers

8.1. Global Deep Vein Thrombosis (DVT) Pumps Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Deep Vein Thrombosis (DVT) Pumps: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. ArjoHuntleigh

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Zimmer Biomet

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Breg

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. DJO

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Devon Medical Products

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Cardinal Health

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Currie Medical Specialties

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Mego Afek AC LTD

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Normatec

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Bio Compression Systems

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. ThermoTek USA

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Deep Vein Thrombosis (DVT) Pumps Market

Figure 4: Global Deep Vein Thrombosis (DVT) Pumps Market: Drivers

Figure 5: Global Deep Vein Thrombosis (DVT) Pumps Market: Challenges

Figure 6: Global Deep Vein Thrombosis (DVT) Pumps Market: Trends

Figure 7: Global Deep Vein Thrombosis (DVT) Pumps Market: Opportunity

Figure 8: Global Deep Vein Thrombosis (DVT) Pumps Market: Restraint

Figure 9: Global Deep Vein Thrombosis (DVT) Pumps Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Deep Vein Thrombosis (DVT) Pumps Market Value (USD Million) By Region

Figure 15: Global Deep Vein Thrombosis (DVT) Pumps Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Deep Vein Thrombosis (DVT) Pumps Market Value (USD Million) By Region

Figure 23: Global Deep Vein Thrombosis (DVT) Pumps Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Deep Vein Thrombosis (DVT) Pumps Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Deep Vein Thrombosis (DVT) Pumps Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Deep Vein Thrombosis (DVT) Pumps Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Deep Vein Thrombosis (DVT) Pumps Market Value (USD Million) By Region

Table 10: Global Deep Vein Thrombosis (DVT) Pumps Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Deep Vein Thrombosis (DVT) Pumps Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Deep Vein Thrombosis (DVT) Pumps Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Deep Vein Thrombosis (DVT) Pumps Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: ArjoHuntleigh Basic Information And Sales Area

Table 31: ArjoHuntleigh. Products Portfolio

Table 32: Zimmer Biomet Basic Information And Sales Area

Table 33: Zimmer Biomet. Products Portfolio

Table 34: Breg Basic Information And Sales Area

Table 35: Breg. Products Portfolio

Table 36: DJO Basic Information And Sales Area

Table 37: DJO. Products Portfolio

Table 38: Devon Medical Products Basic Information And Sales Area

Table 39: Devon Medical Products. Products Portfolio

Table 40: Cardinal Health Basic Information And Sales Area

Table 41: Cardinal Health. Products Portfolio

Table 42: Currie Medical Specialties Basic Information And Sales Area

Table 43: Currie Medical Specialties. Products Portfolio

Table 44: Mego Afek AC LTD Basic Information And Sales Area

Table 45: Mego Afek AC LTD. Products Portfolio

Table 46: Normatec Basic Information And Sales Area

Table 47: Normatec. Products Portfolio

Table 48: Bio Compression Systems Basic Information And Sales Area

Table 49: Bio Compression Systems. Products Portfolio

Table 50: ThermoTek USA Basic Information And Sales Area

Table 51: ThermoTek USA. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Deep Vein Thrombosis (DVT) Pumps Market Value (USD Million) By Region

Table 57: Global Deep Vein Thrombosis (DVT) Pumps Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

FAQs

1. What is the current Deep Vein Thrombosis (DVT) Pumps market size?

As of 2023, the Deep Vein Thrombosis (DVT) Pumps market size is estimated at roughly USD 1.15 billion, reflecting steady demand from hospitals, surgical centers, and home‑care settings worldwide. The valuation incorporates sales of pneumatic, hydraulic and electronic compression devices.

2. What is the projected growth rate for the DVT Pumps market over the next decade?

Forecasts indicate the DVT Pumps market will expand at a compound annual growth rate of 5.8 % between 2024 and 2034, reaching an estimated USD 1.95 billion by 2034. Growth is driven by aging populations and increasing postoperative thrombosis prevention protocols.

3. Which factors are the primary drivers behind market expansion?

Key drivers include rising incidence of deep‑vein thrombosis, greater adoption of minimally invasive surgeries, expanding outpatient care models, and heightened awareness of prophylactic compression therapy among clinicians. Reimbursement improvements in major economies also accelerate device procurement.

4. What challenges could impede market growth?

Challenges comprise high upfront cost of advanced compression systems, limited insurance coverage in emerging markets, patient non‑compliance due to device discomfort, and stringent regulatory pathways that prolong product launch timelines. Additionally, competition from low‑cost alternatives pressures margins.

5. Which regions currently lead the Deep Vein Thrombosis (DVT) Pumps market?

North America remains the dominant region, accounting for over 40 % of global revenue, driven by robust healthcare infrastructure and reimbursement policies. Europe follows closely, while Asia‑Pacific exhibits the fastest growth, propelled by expanding hospital networks and aging demographics.

6. Who are the top companies competing in the DVT Pumps market?

Leading manufacturers include Hill‑Rom (Johnson & Johnson), Becton Dickinson, Smith & Nephew, Medtronic, and LivaNova. These firms differentiate through patented pneumatic technologies, integrated data platforms, and extensive service networks, securing significant market share across multiple geographies.

7. What future opportunities are emerging for the DVT Pumps market?

Future outlook highlights opportunities in digital health integration, such as remote monitoring and AI‑driven compliance analytics, as well as expansion into home‑care and tele‑rehabilitation services. Partnerships with insurers to develop value‑based reimbursement models also present growth potential.

8. How is technology shaping the Deep Vein Thrombosis (DVT) Pumps market?

Advances in sensor‑embedded pumps enable real‑time pressure adjustments, while wireless connectivity supports cloud‑based data aggregation for clinicians. Portable battery designs improve patient mobility, and machine‑learning algorithms predict thrombosis risk, enhancing preventive therapy precision and clinical outcomes.

9. What is the regulatory landscape governing DVT Pumps globally?

Regulatory oversight varies: the U.S. FDA classifies DVT pumps as Class II medical devices requiring 510(k) clearance, while the EU follows MDR classification with CE marking. Asian jurisdictions are tightening standards, demanding clinical evidence and post‑market surveillance to ensure safety.

Contact for Full Report

Loading report content...

Deep Vein Thrombosis (DVT) Pumps Market Outlook, Trends & Forecast 2033

Market Snapshot

Deep Vein Thrombosis (DVT) Pumps Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Deep Vein Thrombosis (DVT) Pumps Segmentation

Deep Vein Thrombosis (DVT) Pumps Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Deep Vein Thrombosis (DVT) Pumps market size?

2. What is the projected growth rate for the DVT Pumps market over the next decade?

3. Which factors are the primary drivers behind market expansion?

4. What challenges could impede market growth?

5. Which regions currently lead the Deep Vein Thrombosis (DVT) Pumps market?

6. Who are the top companies competing in the DVT Pumps market?

7. What future opportunities are emerging for the DVT Pumps market?

8. How is technology shaping the Deep Vein Thrombosis (DVT) Pumps market?

9. What is the regulatory landscape governing DVT Pumps globally?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Deep Vein Thrombosis (DVT) Pumps Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Deep Vein Thrombosis (DVT) Pumps Segmentation

Deep Vein Thrombosis (DVT) Pumps Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Deep Vein Thrombosis (DVT) Pumps market size?

2. What is the projected growth rate for the DVT Pumps market over the next decade?

3. Which factors are the primary drivers behind market expansion?

4. What challenges could impede market growth?

5. Which regions currently lead the Deep Vein Thrombosis (DVT) Pumps market?

6. Who are the top companies competing in the DVT Pumps market?

7. What future opportunities are emerging for the DVT Pumps market?

8. How is technology shaping the Deep Vein Thrombosis (DVT) Pumps market?

9. What is the regulatory landscape governing DVT Pumps globally?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation